Position in REGN
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$10,044
+$7,795 QoQ
Shares Held
13
+225.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Clearstead Trust, LLC holds $1,529,523 across 20 Biotechnology names. REGN ranks #6 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,938 | $1,302,966 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
161 | $71,892 | |
| 3 | ENTA |
Enanta Pharmaceuticals Inc
|
5,064 | $63,958 | |
| 4 | INCY |
Incyte Corp
|
141 | $13,270 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
63 | $11,910 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
13 | $10,044 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
80 | $7,780 | |
| 8 | RPRX |
Royalty Pharma plc
|
132 | $6,332 |
All Filings in REGN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,044 | 13 | Shares | Sole | 2026-05-06 | |
| 2025-09-30 | $2,249 | 4 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $2,100 | 4 | Shares | Sole | 2025-08-08 | |
| No filing history on record for this holder in this stock. | ||||||